Changes in Serum Immunoglobulin Levels Play as Predictors of Treatment Response and Prognosis in Pediatric Idiopathic Nephrotic Syndrome During the Remission Phase

ABSTRACT Background Nephrotic syndrome is an immune‐mediated renal disorder characterized by T‐cell and B‐cell dysfunctions with changes in immunoglobulin (Ig) levels and the IgG:IgM ratio. Therefore, this study aimed to determine whether the serum level of Igs can be considered as an index to predi...

Full description

Saved in:
Bibliographic Details
Published inImmunity, Inflammation and Disease Vol. 13; no. 1; pp. e70144 - n/a
Main Authors sadat Sharif, Amin, Nickravesh, Naghmeh, Heidarzadeh Arani, Marzieh, Azadchehr, Mohammad Javad, Motedayyen, Hossein
Format Journal Article
LanguageEnglish
Published England John Wiley & Sons, Inc 01.01.2025
John Wiley and Sons Inc
Wiley
Subjects
Online AccessGet full text
ISSN2050-4527
2050-4527
DOI10.1002/iid3.70144

Cover

Abstract ABSTRACT Background Nephrotic syndrome is an immune‐mediated renal disorder characterized by T‐cell and B‐cell dysfunctions with changes in immunoglobulin (Ig) levels and the IgG:IgM ratio. Therefore, this study aimed to determine whether the serum level of Igs can be considered as an index to predict the response to treatment and the prognosis of idiopathic nephrotic syndrome (INS) in children in the remission phase. Methods The study population consisted of 38 children with INS in the remission phase and 38 age‐ and sex‐matched healthy children. Blood samples were collected from participants and serum values of IgG, IgM, IgE, and IgA were measured using EISA KITS from Aptech Services. The IgG:IgM ratio was studied in the participants. Results Patients significantly increased IgM and IgE levels compared with healthy subjects, unlike IgG and IgA values (p < 0.001–0.05). Patients with steroid‐resistant nephrotic syndrome (SRNS) had a significant increase in IgM levels compared with those with steroid‐sensitive nephrotic syndrome (SSNS) (p < 0.05). While, subjects with SRNS showed significant reductions in IgG and IgA values (p < 0.01). There were significant differences in the levels of IgG and IgM between steroid‐sensitive patients with and without a history of relapse (p < 0.01). Furthermore, patients with steroid‐independent and frequently relapsing NS showed a significant increase in IgE value compared with that of subjects with steroid‐dependent and relapse (p < 0.05). The ratio of IgG/IgM was significantly reduced in patients compared with healthy individuals (p < 0.05). Other results indicated that there was a significant difference between patients with steroid‐independent and steroid‐dependent who had a history of relapse (p < 0.01). Conclusion Alterations in serum Ig values can be considered as predictors of treatment response and prognosis in pediatric idiopathic nephrotic syndrome during the remission phase.
AbstractList Nephrotic syndrome is an immune-mediated renal disorder characterized by T-cell and B-cell dysfunctions with changes in immunoglobulin (Ig) levels and the IgG:IgM ratio. Therefore, this study aimed to determine whether the serum level of Igs can be considered as an index to predict the response to treatment and the prognosis of idiopathic nephrotic syndrome (INS) in children in the remission phase. The study population consisted of 38 children with INS in the remission phase and 38 age- and sex-matched healthy children. Blood samples were collected from participants and serum values of IgG, IgM, IgE, and IgA were measured using EISA KITS from Aptech Services. The IgG:IgM ratio was studied in the participants. Patients significantly increased IgM and IgE levels compared with healthy subjects, unlike IgG and IgA values (p < 0.001-0.05). Patients with steroid-resistant nephrotic syndrome (SRNS) had a significant increase in IgM levels compared with those with steroid-sensitive nephrotic syndrome (SSNS) (p < 0.05). While, subjects with SRNS showed significant reductions in IgG and IgA values (p < 0.01). There were significant differences in the levels of IgG and IgM between steroid-sensitive patients with and without a history of relapse (p < 0.01). Furthermore, patients with steroid-independent and frequently relapsing NS showed a significant increase in IgE value compared with that of subjects with steroid-dependent and relapse (p < 0.05). The ratio of IgG/IgM was significantly reduced in patients compared with healthy individuals (p < 0.05). Other results indicated that there was a significant difference between patients with steroid-independent and steroid-dependent who had a history of relapse (p < 0.01). Alterations in serum Ig values can be considered as predictors of treatment response and prognosis in pediatric idiopathic nephrotic syndrome during the remission phase.
ABSTRACT Background Nephrotic syndrome is an immune‐mediated renal disorder characterized by T‐cell and B‐cell dysfunctions with changes in immunoglobulin (Ig) levels and the IgG:IgM ratio. Therefore, this study aimed to determine whether the serum level of Igs can be considered as an index to predict the response to treatment and the prognosis of idiopathic nephrotic syndrome (INS) in children in the remission phase. Methods The study population consisted of 38 children with INS in the remission phase and 38 age‐ and sex‐matched healthy children. Blood samples were collected from participants and serum values of IgG, IgM, IgE, and IgA were measured using EISA KITS from Aptech Services. The IgG:IgM ratio was studied in the participants. Results Patients significantly increased IgM and IgE levels compared with healthy subjects, unlike IgG and IgA values (p < 0.001–0.05). Patients with steroid‐resistant nephrotic syndrome (SRNS) had a significant increase in IgM levels compared with those with steroid‐sensitive nephrotic syndrome (SSNS) (p < 0.05). While, subjects with SRNS showed significant reductions in IgG and IgA values (p < 0.01). There were significant differences in the levels of IgG and IgM between steroid‐sensitive patients with and without a history of relapse (p < 0.01). Furthermore, patients with steroid‐independent and frequently relapsing NS showed a significant increase in IgE value compared with that of subjects with steroid‐dependent and relapse (p < 0.05). The ratio of IgG/IgM was significantly reduced in patients compared with healthy individuals (p < 0.05). Other results indicated that there was a significant difference between patients with steroid‐independent and steroid‐dependent who had a history of relapse (p < 0.01). Conclusion Alterations in serum Ig values can be considered as predictors of treatment response and prognosis in pediatric idiopathic nephrotic syndrome during the remission phase.
Nephrotic syndrome is an immune-mediated renal disorder characterized by T-cell and B-cell dysfunctions with changes in immunoglobulin (Ig) levels and the IgG:IgM ratio. Therefore, this study aimed to determine whether the serum level of Igs can be considered as an index to predict the response to treatment and the prognosis of idiopathic nephrotic syndrome (INS) in children in the remission phase.BACKGROUNDNephrotic syndrome is an immune-mediated renal disorder characterized by T-cell and B-cell dysfunctions with changes in immunoglobulin (Ig) levels and the IgG:IgM ratio. Therefore, this study aimed to determine whether the serum level of Igs can be considered as an index to predict the response to treatment and the prognosis of idiopathic nephrotic syndrome (INS) in children in the remission phase.The study population consisted of 38 children with INS in the remission phase and 38 age- and sex-matched healthy children. Blood samples were collected from participants and serum values of IgG, IgM, IgE, and IgA were measured using EISA KITS from Aptech Services. The IgG:IgM ratio was studied in the participants.METHODSThe study population consisted of 38 children with INS in the remission phase and 38 age- and sex-matched healthy children. Blood samples were collected from participants and serum values of IgG, IgM, IgE, and IgA were measured using EISA KITS from Aptech Services. The IgG:IgM ratio was studied in the participants.Patients significantly increased IgM and IgE levels compared with healthy subjects, unlike IgG and IgA values (p < 0.001-0.05). Patients with steroid-resistant nephrotic syndrome (SRNS) had a significant increase in IgM levels compared with those with steroid-sensitive nephrotic syndrome (SSNS) (p < 0.05). While, subjects with SRNS showed significant reductions in IgG and IgA values (p < 0.01). There were significant differences in the levels of IgG and IgM between steroid-sensitive patients with and without a history of relapse (p < 0.01). Furthermore, patients with steroid-independent and frequently relapsing NS showed a significant increase in IgE value compared with that of subjects with steroid-dependent and relapse (p < 0.05). The ratio of IgG/IgM was significantly reduced in patients compared with healthy individuals (p < 0.05). Other results indicated that there was a significant difference between patients with steroid-independent and steroid-dependent who had a history of relapse (p < 0.01).RESULTSPatients significantly increased IgM and IgE levels compared with healthy subjects, unlike IgG and IgA values (p < 0.001-0.05). Patients with steroid-resistant nephrotic syndrome (SRNS) had a significant increase in IgM levels compared with those with steroid-sensitive nephrotic syndrome (SSNS) (p < 0.05). While, subjects with SRNS showed significant reductions in IgG and IgA values (p < 0.01). There were significant differences in the levels of IgG and IgM between steroid-sensitive patients with and without a history of relapse (p < 0.01). Furthermore, patients with steroid-independent and frequently relapsing NS showed a significant increase in IgE value compared with that of subjects with steroid-dependent and relapse (p < 0.05). The ratio of IgG/IgM was significantly reduced in patients compared with healthy individuals (p < 0.05). Other results indicated that there was a significant difference between patients with steroid-independent and steroid-dependent who had a history of relapse (p < 0.01).Alterations in serum Ig values can be considered as predictors of treatment response and prognosis in pediatric idiopathic nephrotic syndrome during the remission phase.CONCLUSIONAlterations in serum Ig values can be considered as predictors of treatment response and prognosis in pediatric idiopathic nephrotic syndrome during the remission phase.
ABSTRACT Background Nephrotic syndrome is an immune‐mediated renal disorder characterized by T‐cell and B‐cell dysfunctions with changes in immunoglobulin (Ig) levels and the IgG:IgM ratio. Therefore, this study aimed to determine whether the serum level of Igs can be considered as an index to predict the response to treatment and the prognosis of idiopathic nephrotic syndrome (INS) in children in the remission phase. Methods The study population consisted of 38 children with INS in the remission phase and 38 age‐ and sex‐matched healthy children. Blood samples were collected from participants and serum values of IgG, IgM, IgE, and IgA were measured using EISA KITS from Aptech Services. The IgG:IgM ratio was studied in the participants. Results Patients significantly increased IgM and IgE levels compared with healthy subjects, unlike IgG and IgA values (p < 0.001–0.05). Patients with steroid‐resistant nephrotic syndrome (SRNS) had a significant increase in IgM levels compared with those with steroid‐sensitive nephrotic syndrome (SSNS) (p < 0.05). While, subjects with SRNS showed significant reductions in IgG and IgA values (p < 0.01). There were significant differences in the levels of IgG and IgM between steroid‐sensitive patients with and without a history of relapse (p < 0.01). Furthermore, patients with steroid‐independent and frequently relapsing NS showed a significant increase in IgE value compared with that of subjects with steroid‐dependent and relapse (p < 0.05). The ratio of IgG/IgM was significantly reduced in patients compared with healthy individuals (p < 0.05). Other results indicated that there was a significant difference between patients with steroid‐independent and steroid‐dependent who had a history of relapse (p < 0.01). Conclusion Alterations in serum Ig values can be considered as predictors of treatment response and prognosis in pediatric idiopathic nephrotic syndrome during the remission phase.
Author Azadchehr, Mohammad Javad
Motedayyen, Hossein
Heidarzadeh Arani, Marzieh
Nickravesh, Naghmeh
sadat Sharif, Amin
AuthorAffiliation 2 Pediatric Department, School of Medicine Kashan University of Medical Sciences Kashan Iran
4 Autoimmune Diseases Research Center Kashan University of Medical Sciences Kashan Iran
1 Pediatric Nephrology Department, Hasheminejad Hospital Iran University of Medical Sciences Tehran Iran
3 Infectious Diseases Research Center Kashan University of Medical Sciences Kashan Iran
AuthorAffiliation_xml – name: 1 Pediatric Nephrology Department, Hasheminejad Hospital Iran University of Medical Sciences Tehran Iran
– name: 3 Infectious Diseases Research Center Kashan University of Medical Sciences Kashan Iran
– name: 4 Autoimmune Diseases Research Center Kashan University of Medical Sciences Kashan Iran
– name: 2 Pediatric Department, School of Medicine Kashan University of Medical Sciences Kashan Iran
Author_xml – sequence: 1
  givenname: Amin
  surname: sadat Sharif
  fullname: sadat Sharif, Amin
  organization: Iran University of Medical Sciences
– sequence: 2
  givenname: Naghmeh
  surname: Nickravesh
  fullname: Nickravesh, Naghmeh
  organization: Kashan University of Medical Sciences
– sequence: 3
  givenname: Marzieh
  surname: Heidarzadeh Arani
  fullname: Heidarzadeh Arani, Marzieh
  organization: Kashan University of Medical Sciences
– sequence: 4
  givenname: Mohammad Javad
  surname: Azadchehr
  fullname: Azadchehr, Mohammad Javad
  organization: Kashan University of Medical Sciences
– sequence: 5
  givenname: Hossein
  orcidid: 0000-0002-7372-4590
  surname: Motedayyen
  fullname: Motedayyen, Hossein
  email: hmotedayyen@gmail.com
  organization: Kashan University of Medical Sciences
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39871511$$D View this record in MEDLINE/PubMed
BookMark eNp9ks1u1DAQgCNUREvphQdAlrggpC12nNjZE0JbfiKtoKLlbE3sSeIqsRc7Kdrn4UXx7paq5cBpRuNvPo1H8zw7ct5hlr1k9JxRmr-z1vBzSVlRPMlOclrSRVHm8uhBfpydxXhDKWWUS06rZ9kxX1aSlYydZL9XPbgOI7GOXGGYR1KP4-x8N_hmHlJxjbc4RHI5wJZAigGN1ZMPkfiWXAeEaUQ3ke8YN95FJOBMgnznfLR762VqgClYTWpj_QamPqVfcdMHP6XsautM8COSizlY15GpxyQbbYzWp-YeIr7InrYwRDy7i6fZj08fr1dfFutvn-vVh_VCl3lVLMq2xaKpCmNaXRi9FGaZ_syXtMoLbBo0AiAHUTKeS9SNMJKBzkGDSe0CBD_N6oPXeLhRm2BHCFvlwap9wYdOQUgzD6gqo5slMI66ZYWEsql41ciywlK2BUeTXO8Prs3cjGh02lGA4ZH08Yuzver8rWJMylxSmQxv7gzB_5wxTiotReMwgEM_R8WZoIXgJasS-vof9MbPwaVd7SkhmBA74auHI93P8vcYEvD2AOjgYwzY3iOMqt2xqd2xqf2xJZgd4F92wO1_SFXXF_zQ8wer4dkZ
Cites_doi 10.3389/fped.2020.591349
10.1016/S0001-4079(19)34320-1
10.1007/s00467-020-04609-0
10.3349/ymj.2010.51.2.239
10.1007/s00467-021-05345-9
10.19082/3728
10.1007/s13312-012-0220-4
10.5812/pedinfect.12101
10.2188/jea.JE20120033
10.4103/1110-2098.163897
10.2215/CJN.08570722
10.1086/522129
10.5812/numonthly.58580
10.1038/ki.1983.30
10.1056/NEJM197507032930103
10.4103/0971-4065.41289
10.1016/j.molimm.2019.07.001
10.2147/PHMT.S100803
ContentType Journal Article
Copyright 2025 The Author(s). published by John Wiley & Sons Ltd.
2025 The Author(s). Immunity, Inflammation and Disease published by John Wiley & Sons Ltd.
2025. This work is published under http://creativecommons.org/licenses/by/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2025 The Author(s). published by John Wiley & Sons Ltd.
– notice: 2025 The Author(s). Immunity, Inflammation and Disease published by John Wiley & Sons Ltd.
– notice: 2025. This work is published under http://creativecommons.org/licenses/by/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1002/iid3.70144
DatabaseName Wiley Online Library Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials Local Electronic Collection Information
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic

Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ - Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: 7X7
  name: Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2050-4527
EndPage n/a
ExternalDocumentID oai_doaj_org_article_8dcb9a13ecf147a5b838b758e57f43ed
PMC11772707
39871511
10_1002_iid3_70144
IID370144
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: This research was supported by the Kashan University of Medical Sciences (98001291).
GroupedDBID 0R~
1OC
24P
53G
5VS
7X7
8-1
8FI
8FJ
AAHHS
AAZKR
ABDBF
ABUWG
ACCFJ
ACCMX
ACUHS
ACXQS
ADBBV
ADKYN
ADPDF
ADRAZ
ADZMN
ADZOD
AEEZP
AEQDE
AFKRA
AIWBW
AJBDE
ALAGY
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AOIJS
AVUZU
BAWUL
BCNDV
BENPR
BPHCQ
BVXVI
CCPQU
DIK
EBS
EJD
ESX
FYUFA
GODZA
GROUPED_DOAJ
HMCUK
HYE
IAO
IHR
INH
ITC
KQ8
M48
M~E
O9-
OK1
OVD
PIMPY
PQQKQ
PROAC
RPM
TEORI
UKHRP
WIN
AAYXX
CITATION
PHGZM
PHGZT
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
PUEGO
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c5284-5ffe4b84ddfc4dc96d9001390824ebbed6aa2a651327ecb6d71ac2acad5286a63
IEDL.DBID M48
ISSN 2050-4527
IngestDate Wed Aug 27 01:29:22 EDT 2025
Thu Aug 21 18:40:23 EDT 2025
Thu Sep 04 21:54:28 EDT 2025
Wed Aug 13 10:04:35 EDT 2025
Thu Aug 28 04:46:16 EDT 2025
Tue Jul 01 00:43:47 EDT 2025
Wed Jan 29 10:50:35 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords immune dysfunctions
idiopathic nephrotic syndrome
immunoglobulins
disease remission
Language English
License Attribution
2025 The Author(s). Immunity, Inflammation and Disease published by John Wiley & Sons Ltd.
This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5284-5ffe4b84ddfc4dc96d9001390824ebbed6aa2a651327ecb6d71ac2acad5286a63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-7372-4590
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1002/iid3.70144
PMID 39871511
PQID 3160661667
PQPubID 2034588
PageCount 7
ParticipantIDs doaj_primary_oai_doaj_org_article_8dcb9a13ecf147a5b838b758e57f43ed
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11772707
proquest_miscellaneous_3160463518
proquest_journals_3160661667
pubmed_primary_39871511
crossref_primary_10_1002_iid3_70144
wiley_primary_10_1002_iid3_70144_IID370144
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate January 2025
PublicationDateYYYYMMDD 2025-01-01
PublicationDate_xml – month: 01
  year: 2025
  text: January 2025
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Bognor Regis
– name: Hoboken
PublicationTitle Immunity, Inflammation and Disease
PublicationTitleAlternate Immun Inflamm Dis
PublicationYear 2025
Publisher John Wiley & Sons, Inc
John Wiley and Sons Inc
Wiley
Publisher_xml – name: John Wiley & Sons, Inc
– name: John Wiley and Sons Inc
– name: Wiley
References 2017; 8
1987; 8
2023; 18
2008; 18
1975; 293
2016; 93
2014; 63
2017; 9
2009; 139
2020; 8
2021; 36
2018; 6
2015; 28
2002; 186
2005; 122
2019; 21
2019; 114
2022; 37
2012; 49
2018; 10
2012; 22
2008; 197
2018; 15
2010; 51
1983; 23
e_1_2_10_23_1
e_1_2_10_24_1
e_1_2_10_21_1
e_1_2_10_20_1
Rezagholizamenjany M. (e_1_2_10_9_1) 2019; 21
Kodner C. (e_1_2_10_18_1) 2016; 93
e_1_2_10_2_1
e_1_2_10_3_1
e_1_2_10_19_1
e_1_2_10_5_1
Al‐Assadi A. B. (e_1_2_10_16_1) 2018; 15
e_1_2_10_17_1
e_1_2_10_8_1
e_1_2_10_14_1
e_1_2_10_7_1
e_1_2_10_15_1
e_1_2_10_12_1
e_1_2_10_13_1
e_1_2_10_10_1
Chen C. H. (e_1_2_10_22_1) 1987; 8
Bagga A. (e_1_2_10_4_1) 2005; 122
Seigneux S. (e_1_2_10_6_1) 2009; 139
Tomczyk S. (e_1_2_10_11_1) 2014; 63
e_1_2_10_25_1
e_1_2_10_26_1
References_xml – volume: 6
  issue: 3
  year: 2018
  article-title: Detection of Extended‐Spectrum Beta‐Lactamases in Isolates and It's Correlation With Vesicoureteral Reflux Nephropathy
  publication-title: Archives of Pediatric Infectious Diseases
– volume: 21
  start-page: 1
  issue: 7
  year: 2019
  end-page: 7
  article-title: Nephrotic Syndrome in Children With This Condition
  publication-title: Journal of Arak University of Medical Sciences
– volume: 9
  start-page: 3728
  issue: 2
  year: 2017
  end-page: 3732
  article-title: Immunoglobulin G and M Levels in Childhood Nephrotic Syndrome: Two Centers Egyptian Study
  publication-title: Electronic Physician
– volume: 8
  start-page: 75
  issue: 2
  year: 1987
  end-page: 80
  article-title: Enhanced Suppressor T Cell Activity Resulting in Increased IgM and Decreased IgG Productions in Children With Minimal Change Nephrotic Syndrome
  publication-title: International Journal of Pediatric Nephrology
– volume: 15
  start-page: 1011
  issue: 4
  year: 2018
  end-page: 1016
  article-title: Serum Immunoglobulin G, M and A Levels in Children With Nephrotic Syndrome and Its Correlation With Biochemical Parameters
  publication-title: Pakistan Journal of Biotechnology
– volume: 197
  start-page: S237
  issue: S2
  year: 2008
  end-page: S241
  article-title: Strategies for Herpes Zoster Vaccination of Immunocompromised Patients
  publication-title: Journal of Infectious Diseases
– volume: 18
  start-page: 31
  issue: 1
  year: 2008
  end-page: 39
  article-title: Revised Guidelines for Management of Steroid‐Sensitive Nephrotic Syndrome
  publication-title: Indian Journal of Nephrology
– volume: 8
  year: 2020
  article-title: Interleukin‐4 and Interleukin‐13 Gene Polymorphisms in Children With Idiopathic Nephrotic Syndrome
  publication-title: Frontiers in Pediatrics
– volume: 93
  start-page: 479
  issue: 6
  year: 2016
  end-page: 485
  article-title: Diagnosis and Management of Nephrotic Syndrome in Adults
  publication-title: American Family Physician
– volume: 23
  start-page: 380
  issue: 2
  year: 1983
  end-page: 386
  article-title: Immunoglobulin Synthesis by Peripheral Blood Mononuclear Cells in Minimal Change Nephrotic Syndrome
  publication-title: Kidney International
– volume: 293
  start-page: 8
  issue: 1
  year: 1975
  end-page: 12
  article-title: Serum Immunoglobulins in the Nephrotic Syndrome: A Possible Cause of Minimal‐Change Nephrotic Syndrome
  publication-title: New England Journal of Medicine
– volume: 8
  start-page: 29
  year: 2017
  end-page: 37
  article-title: Steroid‐Resistant Nephrotic Syndrome: Past and Current Perspectives
  publication-title: Pediatric Health, Medicine and Therapeutics
– volume: 122
  start-page: 13
  issue: 1
  year: 2005
  end-page: 28
  article-title: Nephrotic Syndrome in Children
  publication-title: Indian Journal of Medical Research
– volume: 49
  start-page: 881
  year: 2012
  end-page: 887
  article-title: Disease Course in Steroid Sensitive Nephrotic Syndrome
  publication-title: Indian Pediatrics
– volume: 51
  start-page: 239
  issue: 2
  year: 2010
  article-title: Antibody Status in Children With Steroid‐Sensitive Nephrotic Syndrome
  publication-title: Yonsei Medical Journal
– volume: 36
  start-page: 1397
  issue: 6
  year: 2021
  end-page: 1405
  article-title: Rituximab in Children With Steroid Sensitive Nephrotic Syndrome: In Quest of the Optimal Regimen
  publication-title: Pediatric Nephrology
– volume: 18
  start-page: 533
  issue: 4
  year: 2023
  end-page: 548
  article-title: Use of Rituximab in Childhood Idiopathic Nephrotic Syndrome
  publication-title: Clinical Journal of the American Society of Nephrology
– volume: 114
  start-page: 162
  year: 2019
  end-page: 170
  article-title: Circulating Follicular T Helper Cells Are Possibly Associated With Low Levels of Serum Immunoglobulin G Due to Impaired Immunoglobulin Class‐Switch Recombination of B Cells in Children With Primary Nephrotic Syndrome
  publication-title: Molecular Immunology
– volume: 28
  start-page: 431
  issue: 2
  year: 2015
  article-title: Serum Immunoglobulin G, M, and IgG:IgM Ratio as Predictors for Outcome of Childhood Nephrotic Syndrome
  publication-title: Menoufia Medical Journal
– volume: 22
  start-page: 517
  issue: 6
  year: 2012
  end-page: 522
  article-title: Epidemiology and Predictors of End‐Stage Renal Disease in Taiwanese Children With Idiopathic Nephrotic Syndrome
  publication-title: Journal of Epidemiology
– volume: 10
  issue: 2
  year: 2018
  article-title: Nephrotoxic Effect of Gentamicin and Amikacin in Neonates With Infection
  publication-title: Nephro‐Urology Monthly
– volume: 139
  start-page: 416
  issue: 29
  year: 2009
  end-page: 422
  article-title: Management of Patients With Nephrotic Syndrome
  publication-title: Swiss Medical Weekly
– volume: 186
  start-page: 683
  issue: 3
  year: 2002
  end-page: 690
  article-title: New Insights About Immunopathology of Lipoid Nephrosis
  publication-title: Bulletin de l'Academie nationale de medecine
– volume: 63
  start-page: 822
  issue: 37
  year: 2014
  end-page: 825
  article-title: Use of 13‐Valent Pneumococcal Conjugate Vaccine and 23‐Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
  publication-title: Morbidity and Mortality Weekly Report
– volume: 37
  start-page: 927
  issue: 5
  year: 2022
  end-page: 931
  article-title: Hypogammaglobulinaemia Following Rituximab Therapy in Childhood Nephrotic Syndrome
  publication-title: Pediatric Nephrology
– volume: 15
  start-page: 1011
  issue: 4
  year: 2018
  ident: e_1_2_10_16_1
  article-title: Serum Immunoglobulin G, M and A Levels in Children With Nephrotic Syndrome and Its Correlation With Biochemical Parameters
  publication-title: Pakistan Journal of Biotechnology
– ident: e_1_2_10_3_1
  doi: 10.3389/fped.2020.591349
– ident: e_1_2_10_5_1
  doi: 10.1016/S0001-4079(19)34320-1
– ident: e_1_2_10_23_1
  doi: 10.1007/s00467-020-04609-0
– ident: e_1_2_10_17_1
  doi: 10.3349/ymj.2010.51.2.239
– ident: e_1_2_10_25_1
  doi: 10.1007/s00467-021-05345-9
– ident: e_1_2_10_15_1
  doi: 10.19082/3728
– ident: e_1_2_10_13_1
  doi: 10.1007/s13312-012-0220-4
– ident: e_1_2_10_7_1
  doi: 10.5812/pedinfect.12101
– ident: e_1_2_10_2_1
  doi: 10.2188/jea.JE20120033
– ident: e_1_2_10_26_1
  doi: 10.4103/1110-2098.163897
– ident: e_1_2_10_24_1
  doi: 10.2215/CJN.08570722
– volume: 8
  start-page: 75
  issue: 2
  year: 1987
  ident: e_1_2_10_22_1
  article-title: Enhanced Suppressor T Cell Activity Resulting in Increased IgM and Decreased IgG Productions in Children With Minimal Change Nephrotic Syndrome
  publication-title: International Journal of Pediatric Nephrology
– ident: e_1_2_10_12_1
  doi: 10.1086/522129
– volume: 93
  start-page: 479
  issue: 6
  year: 2016
  ident: e_1_2_10_18_1
  article-title: Diagnosis and Management of Nephrotic Syndrome in Adults
  publication-title: American Family Physician
– volume: 122
  start-page: 13
  issue: 1
  year: 2005
  ident: e_1_2_10_4_1
  article-title: Nephrotic Syndrome in Children
  publication-title: Indian Journal of Medical Research
– ident: e_1_2_10_8_1
  doi: 10.5812/numonthly.58580
– ident: e_1_2_10_21_1
  doi: 10.1038/ki.1983.30
– ident: e_1_2_10_14_1
  doi: 10.1056/NEJM197507032930103
– ident: e_1_2_10_19_1
  doi: 10.4103/0971-4065.41289
– volume: 21
  start-page: 1
  issue: 7
  year: 2019
  ident: e_1_2_10_9_1
  article-title: Nephrotic Syndrome in Children With This Condition
  publication-title: Journal of Arak University of Medical Sciences
– volume: 139
  start-page: 416
  issue: 29
  year: 2009
  ident: e_1_2_10_6_1
  article-title: Management of Patients With Nephrotic Syndrome
  publication-title: Swiss Medical Weekly
– ident: e_1_2_10_10_1
  doi: 10.1016/j.molimm.2019.07.001
– ident: e_1_2_10_20_1
  doi: 10.2147/PHMT.S100803
– volume: 63
  start-page: 822
  issue: 37
  year: 2014
  ident: e_1_2_10_11_1
  article-title: Use of 13‐Valent Pneumococcal Conjugate Vaccine and 23‐Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
  publication-title: Morbidity and Mortality Weekly Report
SSID ssj0001037308
Score 2.2787218
Snippet ABSTRACT Background Nephrotic syndrome is an immune‐mediated renal disorder characterized by T‐cell and B‐cell dysfunctions with changes in immunoglobulin (Ig)...
Nephrotic syndrome is an immune-mediated renal disorder characterized by T-cell and B-cell dysfunctions with changes in immunoglobulin (Ig) levels and the...
ABSTRACT Background Nephrotic syndrome is an immune‐mediated renal disorder characterized by T‐cell and B‐cell dysfunctions with changes in immunoglobulin (Ig)...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage e70144
SubjectTerms Adolescent
Antibodies
Case-Control Studies
Child
Child, Preschool
Cytokines
Demographics
disease remission
Female
Humans
idiopathic nephrotic syndrome
immune dysfunctions
Immunoglobulin A - blood
Immunoglobulin E - blood
Immunoglobulin G - blood
Immunoglobulin M - blood
immunoglobulins
Immunoglobulins - blood
Infections
Kidney diseases
Lymphocytes
Male
Nephrotic Syndrome - blood
Nephrotic Syndrome - diagnosis
Nephrotic Syndrome - drug therapy
Nephrotic Syndrome - immunology
Original
Patients
Pediatrics
Prognosis
Proteins
Remission (Medicine)
Remission Induction
Steroids
Treatment Outcome
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELVQJSQuiPIZKMgITkihSZw48REoVRehqoJW6s0af6mRSoK63UN_T_8oM3Y22hUILpw22jher-c582yP3zD21lahAHTNuXKyyWuvuhysU3kAQGdj6GhnVPs8lkdn9Zfz5nwj1RfFhCV54NRx-52zRkEpvA1l3UJjOtEZJLm-aUMtvKO3b6GKjclUXF0pBEK3m_VIq_2-d-J9S_OHLQ8Uhfr_xC5_D5LcJK_R-xw-YPcn2sg_pObusjt-eMjupkSSN4_YbToksOT9wHH0r37wBZ37GEnug0LN-VeKDVryk0u44YCfV7Q_Q4l2-Bj46TrYnH9LEbOew-Cw0EhReH2sdU7pwReuH2MeY8uPPUJhxCbx75PwAT-Ixx450kqsDDFEi3H85AJ95WN2dvj59NNRPqVfyG2DTitvQvC16Wrngq2dVdKpSBiRNNTeGO8kQAWywfls662Rri3BVmDB4eMSpHjCdoZx8M8YJ9m4IAHJJFaJlgS8LEtpO4MIcUpl7M3aJPpnUtnQSU-50mQ4HQ2XsY9krbkEKWPHLxAvesKL_hdeMra3trWehutSi5LmcaWUbcZez7exk2j3BAY_rlKZGulZ2WXsaYLG3BKhcN6J1DVj3RZotpq6fWfoL6KYN22aV22BP_wu4usv_18vFgciXj3_Hz3xgt2rKJlxXE_aYzvXVyv_EhnWtXkVB9Mvywcofg
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCIkL4k1KWxnBCSl0Ezt-nBClVF2EqgpaaW-WX2kjQdLudg_9PfxRZpxs2hWop11tvI6TGXu-GY-_IeS9L-uJBdOc6yCqnEetcuuDzmtrwdg4PNqZ2D6PxOEp_zarZkPAbTGkVa7WxLRQh85jjHyXFQi1CyHkp4vLHKtG4e7qUELjPnmQqMtAn-VM3sRYJgwUWI2spOVu0wT2UaIXsWaHEl3__zDmv6mStyFsskEHT8jjATzSz720n5J7sX1GHvblJK-fkz_9UYEFbVoKa8DyN53i6Y8OST8w4Zx-xwyhBT3-Za-phc857tJguR3a1fRklXJOf_R5s5HaNkCjDnPxmtTrWNiDTkPTpWrGnh5FUIgOhkR_DvQHdD8dfqQALqEz0CQMydHjc7CYL8jpwdeTL4f5UIQh9xWYrryq68id4iHUngevRdAJNgJ04NG5GIS1pRUVeLUyeieCLKwvrbcB_i6sYC_JRtu18TWhSB5XCwuQErqMHtRBg_spvHKgJ0HrjLxbicRc9FwbpmdVLg0KziTBZWQPpTW2QH7s9EM3PzPDdDMqeKdtweAuBZe2coopB65RrGTNWQwZ2VrJ2gyTdmFuVCwjb8fL8JJwD8W2sVv2bTiAtEJl5FWvGuNImAbvEwBsRtSa0qwNdf1K25wnSm_cOi_lBG78IenXHc9vptN9lr5t3v0Qb8ijEosVp3jRFtm4mi_jNiCoK7eTpslfyH4fCA
  priority: 102
  providerName: ProQuest
– databaseName: Wiley Online Library Open Access
  dbid: 24P
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9RAEB9qRfCl-G20yoo-CbH52Gyy4ItaS0-kHNpC38LsR2xAk3LXe-jf4z_qzCaX81AEny5cNptNZjbzm92Z3wC8slmTIJnmWDtVxNLrKkbrdNwgkrExnNoZ2D5P1PGZ_HRenO_A23UuzMAPMS248cwI32ue4GiWBxvS0LZ1-ZuSHYIbcJNza7lwQybnmxWWJCf1DSXpkiKJZZGVEz9pdrC5fMsiBeL-v6HNP4MmfwezwRod3YG9EUaKd4Pc78KO7-7BraGw5PV9-DkkDSxF2wn6Gqx-iBnngfRM_8Gh5-Izxwotxfw7Xguk3wXv13DhHdE34nQdfC6-DBG0XmDnqFHPUXlt6HUq8SFmru1DXWMrTjypRk9DEl9HIgRxGNIgBcFM6ox0ihfnxPyCbOcDODv6ePrhOB7LMcS2ICMWF03jpamkc42VzmrldACQBCKkN8Y7hZihKsi_Lb01ypUp2gwtOrpcocofwm7Xd_4xCKaRaxQSuKQuvSXF0OSIKlsZ0hindQQv1yKpLwfWjXrgV85qFlwdBBfBe5bW1IKZssMf_eJbPU68unLWaExzuksqSyxMlVeGnCRflI3MvYtgfy3repy-yzpP2a9LlSojeDGdppfEuynY-X41tJEE19IqgkeDakwjyTX5oQRlI6i2lGZrqNtnuvYikHvzJnpWJnTj10G__vH89Wx2mIejJ__T-CnczriIcVhH2ofdq8XKPyNkdWWehwn0C--LIV8
  priority: 102
  providerName: Wiley-Blackwell
Title Changes in Serum Immunoglobulin Levels Play as Predictors of Treatment Response and Prognosis in Pediatric Idiopathic Nephrotic Syndrome During the Remission Phase
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fiid3.70144
https://www.ncbi.nlm.nih.gov/pubmed/39871511
https://www.proquest.com/docview/3160661667
https://www.proquest.com/docview/3160463518
https://pubmed.ncbi.nlm.nih.gov/PMC11772707
https://doaj.org/article/8dcb9a13ecf147a5b838b758e57f43ed
Volume 13
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFD7aRUi8IO4LjMoInpAycnHs-AEhxjatCKpqrFLfIt_CIm3JaFeJ_h7-KMfORauYEC9N1TiOE3_u-Y59_B2AtzopI4mmORSGZSG1Ig-lNiIspURjo9zWTq_2OWGnM_plns23oM_f2b3A5Z2uncsnNVtcHvz6uf6IA_5DJyD6vqpMesCda7ANu2iRmHPCvnU038-1RCkC2Seni7IopFnCB6XS25dv2CYv4X8X7_w7fPI2rfV26eQhPOgIJfnUIuARbNn6MdxrU0yun8DvdvvAklQ1wf-F1RUZux0hjRMCcUHo5KuLGlqS6aVcE4nHhVu5cSl4SFOS8z4MnZy1sbSWyNpgocbF51W-1iHZBxmbqvEZjjWZWARJg00i3ztJBHLkN0QSJJxYGaLLTdOR6QVa0acwOzk-_3wadokZQp2hOQuzsrRU5dSYUlOjBTPCU0mkE9QqZQ2TMpEsQ0-XW62Y4bHUidTS4OVMsvQZ7NRNbfeAOEG5kkmkmVil1QgRgS4p07lC7BghAnjTd0lx3epvFK3SclK4jit8xwVw6HprKOE0s_0PzeJH0Q3BIjdaCRmneJeYcpmpPM0Vuks24yVNrQlgv-_rosdhkcbOw4sZ4wG8Hk7jS3LrKrK2zaotQ5G4xXkAz1toDC1JBXqkSGoDyDdAs9HUzTN1deFlvt1yesIjvPE7j69_PH8xHh-l_tuL_2jlS7ifuCzGfiJpH3ZuFiv7CqnVjRrBdkKn-MnnfAS7h8eT6dnIT1OM_Ij6A-bSKRs
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFD4anRC8IO4EBhgBL0jZmpsTPyDE6KaGlaoanbS34NjOFmkko12F-nt45zdyjpN0VKC97alV4zpOzmef79jnAvBG-UVfomp2heaRGxqRuFJp4RZSorLJKbTTZvsc8-FR-Pk4Ot6A310sDLlVdmuiXah1rWiPfCfwiGp7nMcfzn-4VDWKTle7EhoNLA7M8ieabPP36QDl-9b39_emn4ZuW1XAVRGuxW5UFCbMk1DrQoVaCa6F5UGoC0OT50ZzKX3JIzTTYqNyrmNPKl8qqfHvXPIA-70BmyFFtPZgc3dvPDm83NXpBzhlklUeVH-nLHWwHZPdsqb5bIGA_7Haf50z_ybNVuvt34U7LV1lHxt83YMNU92Hm00By-UD-NUEJ8xZWTFcdRbfWUrxJjWlGSEXdzYin6Q5m5zJJZP4OaNzISrww-qCTTsnd3bYeOoaJiuNjWry_ittr6tSIizVZW3rJys2NgjBGofEvrYJF9jAhlsypLPYGWKXNgHZ5BR19EM4uhYBPYJeVVfmCTBKV1dwiSQWuzQKASjQ4OUqyRGZWggHXnciyc6b7B5Zk8fZz0hwmRWcA7skrVULyshtf6hnJ1k7wbNEq1xIL8C7eGEsozwJkhyNMRPFRRgY7cBWJ-usXSbm2SWoHXi1uowviU5tZGXqRdMmRFroJQ48bqCxGkkg0N5FyuxAsgaataGuX6nKU5tEnA7r_biPN35n8XXF82dpOgjst6dXP8RLuDWcfhllo3R88Axu-1Qq2e5WbUHvYrYwz5G_XeQv2knD4Nt1z9M_zk5exw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VIhAXxBtDgUXABckk9tpr-4AQEKKaVlEErZSb2ZeppdYuSSOU38O_4Ncxs7ZTIlBvPSWKN-u15_XN7jwAXuqwHEo0zX5mROxHNkt9qU3ml1KisVGU2umqfU7E7mH0eRbPtuB3nwtDYZW9TnSK2jSa9sgHPCCoHQiRDMouLGI6Gr87_eFTByk6ae3babQssmdXP9F9W7zNR0jrV2E4_nTwcdfvOgz4Oka97MdlaSOVRsaUOjI6EyZzmAjtYmSVskZIGUoRo8uWWK2ESQKpQ6mlwb8LKTjOewWuJhxRFcpSMkvO93eGHIUnXVdEDQdVZfibhDyYDRvoWgX8D9_-G6b5N3x29m98C252wJW9bzntNmzZ-g5ca1tZru7CrzZNYcGqmqH-WZ6wnDJPGio4QsHubJ-ikxZseixXTOLnnE6IqNUPa0p20Ie7sy9tzK5lsjY4qKE4wMrNum4qwnJTNa6TsmYTi8zY4JLY1670Ahu5xEuGwBYnQy6m7UA2PUJrfQ8OL4U892G7bmr7EBgVriuFRDiLU1qNrJih6yt0qpBHTZZ58KInSXHa1vko2orOYUGEKxzhPPhA1FqPoNrc7odm_r3oRL1IjVaZDDjeJYgSGauUpwrdMhsnZcSt8WCnp3XRKYxFcc7eHjxfX8aXROc3srbNsh0TIUAMUg8etKyxXgnP0PNF8OxBusE0G0vdvFJXR66cOB3bh8kQb_za8dcFz1_k-Yi7b48ufohncB2ls9jPJ3uP4UZIPZPdttUObJ_Nl_YJArkz9dRJDINvly2ifwDH32GO
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Changes+in+Serum+Immunoglobulin+Levels+Play+as+Predictors+of+Treatment+Response+and+Prognosis+in+Pediatric+Idiopathic+Nephrotic+Syndrome+During+the+Remission+Phase&rft.jtitle=Immunity%2C+Inflammation+and+Disease&rft.au=Sadat+Sharif%2C+Amin&rft.au=Nickravesh%2C+Naghmeh&rft.au=Heidarzadeh+Arani%2C+Marzieh&rft.au=Azadchehr%2C+Mohammad+Javad&rft.date=2025-01-01&rft.issn=2050-4527&rft.eissn=2050-4527&rft.volume=13&rft.issue=1&rft.spage=e70144&rft_id=info:doi/10.1002%2Fiid3.70144&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2050-4527&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2050-4527&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2050-4527&client=summon